RESUMO
BACKGROUND: Retroperitoneal abscess (RA) is an unusual life-threatening disease that has insidious and occult presentations. Although the incidence of this disease is low, diagnosis and treatment are challenging due to its nonspecific presentation and the complex anatomy of the retroperitoneal space. Recently, we experienced one case of a RA with extensive thrombophlebitis of the portal venous system. CASE PRESENTATION: An 80-year-old male presented to the emergency room with symptoms and signs of septic shock; however, the decision making for diagnosis and treatment was difficult, as no clinical and radiological evidence supported key findings regarding the origin of sepsis. Although this patient eventually recovered after surgical drainage, we suggested that more straightforward diagnostic and treatment procedures were required in this patient to avoid possible critical complications. Through a retrospective review of operative findings, patient history, and microbiology, we found that the RA in this patient was caused by lumbar acupuncture, which is usually performed for the management of chronic back pain with long needles. CONCLUSION: Early surgical intervention should be considered for RA whenever the patient does not respond to broad-spectrum antibiotic treatment. Acupuncture is a possible cause of otherwise unexplained soft tissue infections, such as RA, especially in Asian countries.
Assuntos
Abscesso Abdominal/etiologia , Abscesso/etiologia , Terapia por Acupuntura/efeitos adversos , Tromboflebite/etiologia , Idoso de 80 Anos ou mais , Humanos , Região Lombossacral , Masculino , Espaço Retroperitoneal/patologiaRESUMO
BACKGROUND: Although superficial thrombophlebitis of the upper extremity represents a frequent complication of intravenous catheters inserted into the peripheral veins of the forearm or hand, no consensus exists on the optimal management of this condition in clinical practice. OBJECTIVES: To summarise the evidence from randomised clinical trials (RCTs) concerning the efficacy and safety of (topical, oral or parenteral) medical therapy of superficial thrombophlebitis of the upper extremity. SEARCH METHODS: The Cochrane Vascular Group Trials Search Co-ordinator searched the Specialised Register (last searched April 2015) and the Cochrane Register of Studies (2015, Issue 3). Clinical trials registries were searched up to April 2015. SELECTION CRITERIA: RCTs comparing any (topical, oral or parenteral) medical treatment to no intervention or placebo, or comparing two different medical interventions (e.g. a different variant scheme or regimen of the same intervention or a different pharmacological type of treatment). DATA COLLECTION AND ANALYSIS: We extracted data on methodological quality, patient characteristics, interventions and outcomes, including improvement of signs and symptoms as the primary effectiveness outcome, and number of participants experiencing side effects of the study treatments as the primary safety outcome. MAIN RESULTS: We identified 13 studies (917 participants). The evaluated treatment modalities consisted of a topical treatment (11 studies), an oral treatment (2 studies) and a parenteral treatment (2 studies). Seven studies used a placebo or no intervention control group, whereas all others also or solely compared active treatment groups. No study evaluated the effects of ice or the application of cold or hot bandages. Overall, the risk of bias in individual trials was moderate to high, although poor reporting hampered a full appreciation of the risk in most studies. The overall quality of the evidence for each of the outcomes varied from low to moderate mainly due to risk of bias and imprecision, with only single trials contributing to most comparisons. Data on primary outcomes improvement of signs and symptoms and side effects attributed to the study treatment could not be statistically pooled because of the between-study differences in comparisons, outcomes and type of instruments to measure outcomes.An array of topical treatments, such as heparinoid or diclofenac gels, improved pain compared to placebo or no intervention. Compared to placebo, oral non-steroidal anti-inflammatory drugs reduced signs and symptoms intensity. Safety issues were reported sparsely and were not available for some interventions, such as notoginseny creams, parenteral low-molecular-weight heparin or defibrotide. Although several trials reported on adverse events with topical heparinoid creams, Essaven gel or phlebolan versus control, the trials were underpowered to adequately measure any differences between treatment modalities. Where reported, adverse events with topical treatments consisted mainly of local allergic reactions. Only one study of 15 participants assessed thrombus extension and symptomatic venous thromboembolism with either oral non-steroidal anti-inflammatory drugs or low-molecular-weight heparin, and it reported no cases of either. No study reported on the development of suppurative phlebitis, catheter-related bloodstream infections or quality of life. AUTHORS' CONCLUSIONS: The evidence about the treatment of acute infusion superficial thrombophlebitis is limited and of low quality. Data appear too preliminary to assess the effectiveness and safety of topical treatments, systemic anticoagulation or oral non-steroidal anti-inflammatory drugs.
Assuntos
Anti-Inflamatórios/administração & dosagem , Anticoagulantes/administração & dosagem , Cateterismo Periférico/efeitos adversos , Tromboflebite/tratamento farmacológico , Extremidade Superior , Dalteparina/administração & dosagem , Diclofenaco/administração & dosagem , Combinação de Medicamentos , Medicamentos de Ervas Chinesas/administração & dosagem , Escina/administração & dosagem , Géis/administração & dosagem , Heparina/administração & dosagem , Heparinoides/administração & dosagem , Humanos , Ibuprofeno/administração & dosagem , Nitroglicerina/administração & dosagem , Nitroglicerina/análogos & derivados , Poliéster Sulfúrico de Pentosana/administração & dosagem , Fosfolipídeos/administração & dosagem , Polidesoxirribonucleotídeos/administração & dosagem , Ensaios Clínicos Controlados Aleatórios como Assunto , Tromboflebite/etiologiaRESUMO
Less invasive endovenous techniques have been shown to be as effective as open surgery in the treatment of varicose veins. Furthermore, they cause less postoperative bruising and pain and enable early return to normal activities and work. Tumescent anaesthesia is safe and obviates complications of general or spinal anaesthesia. Drawbacks are a steep learning curve and painful administration during treatment. Tumescentless techniques like Clarivein™ or VenaSeal™ Sapheon Closure System are recently under investigation. Short-term results of VenaSeal™ are comparable with thermal ablation. The procedure is safe without serious adverse events. Perioperative pain and patient discomfort with this tumescentless approach is minimal but postoperative recovery is temporarily hindered by thrombophlebitis in 14-15 % of patients. One-year results in a small feasibility study has demonstrated durable closure at this endpoint. No longer-term results are available. A randomized control trial between VenaSeal™ and Covidien ClosureFast™ is in a preparatory phase.
Assuntos
Cianoacrilatos/administração & dosagem , Procedimentos Endovasculares/métodos , Soluções Esclerosantes/administração & dosagem , Escleroterapia/métodos , Varizes/terapia , Insuficiência Venosa/terapia , Anestesia Local , Animais , Competência Clínica , Cianoacrilatos/efeitos adversos , Procedimentos Endovasculares/efeitos adversos , Procedimentos Endovasculares/instrumentação , Desenho de Equipamento , Humanos , Curva de Aprendizado , Dor/etiologia , Soluções Esclerosantes/efeitos adversos , Escleroterapia/efeitos adversos , Escleroterapia/instrumentação , Tromboflebite/etiologia , Fatores de Tempo , Resultado do Tratamento , Varizes/diagnóstico , Dispositivos de Acesso Vascular , Insuficiência Venosa/diagnósticoRESUMO
UNLABELLED: Homocysteinuria is a metabolic disorder with defect in genes encoding for methionine metabolism enzymes. The clinical features consist in: ophthalmic, neurological, orthopedic and vascular manifestations. It is generally diagnosed in childhood. Vascular involvements characterize adult's forms. We report one case. OBSERVATION: A 26-year-old man, who has lentis ectopia and a recent epilepsy, was hospitalized for deep vein thrombosis. Regarding the marfanoid phenotype and the high level homocysteinemia (231 micromol/L), homocysteinuria was suspected. Amino acid chromatography and reduced CBS activity were used to confirm the diagnosis. Vitamin enriched diet with vitamin B6 and folates has reduced slightly the homocysteine level. CONCLUSION: Homocysteinuria must be diagnosed early since a simple vitamin supply could ameliorate prognosis and decrease complications.
Assuntos
Homocistinúria/diagnóstico , Anormalidades Múltiplas/genética , Adulto , Consanguinidade , Cistationina beta-Sintase/genética , Epilepsias Parciais/etiologia , Ácido Fólico/uso terapêutico , Lobo Frontal/anormalidades , Homocistinúria/complicações , Homocistinúria/tratamento farmacológico , Humanos , Hiper-Homocisteinemia/diagnóstico , Hiper-Homocisteinemia/etiologia , Subluxação do Cristalino/etiologia , Masculino , Tromboflebite/etiologia , Vitamina B 6/uso terapêuticoRESUMO
OBJECTIVE: To describe lung injuries in autopsied pediatric patients (neonates through 15 years old) subjected or not to total parenteral nutrition, in an intensive care unit. METHODS: Sections from six paraffin-embedded lung fragments, from 114 children were studied by routine staining. Demographic, clinical and therapeutic data were retrieved from the records. Statistical analysis was performed using Statistical Package for the Social Sciences. RESULTS: The 114 patients were divided in two groups: 50 who were treated with total parenteral nutrition with lipid emulsion and 64 who did not receive total parenteral nutrition. The two groups did not differ in gender (p = 0.654), age (p = 0.682) or body weight (p = 0.175), but duration of hospital stay (p = 0.000), prematurity (p = 0.008) and treatment with blood products (p = 0.009) were all higher in the group treated with total parenteral nutrition. All patients received mechanical ventilation during hospitalization. Chi-square comparisons showed that diffuse alveolar injury (p = 0.022), pulmonary fibrosis (p = 0.019), pneumocyte hyperplasia (p = 0.004), microthromboembolism (p = 0.047) and thrombophlebitis (0.033) all exhibited a significant relationship with total parenteral nutrition. However, a multivariate analysis by logistic regression, taking into account prematurity and duration of hospital stay, demonstrated that total parenteral nutrition was an independent factor only with respect of pulmonary fibrosis. CONCLUSION: Although lung injuries were significantly more frequent in children who had received total parenteral nutrition, it was impossible to conclude that the lipid infusion had a direct relationship with these injuries, because prematurity and duration of hospital stay were significant co-factors.
Assuntos
Pulmão/patologia , Nutrição Parenteral Total , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Hiperplasia/etiologia , Hiperplasia/patologia , Lactente , Recém-Nascido , Unidades de Terapia Intensiva Pediátrica , Tempo de Internação , Modelos Logísticos , Masculino , Análise Multivariada , Nutrição Parenteral Total/efeitos adversos , Alvéolos Pulmonares/patologia , Embolia Pulmonar/etiologia , Embolia Pulmonar/patologia , Fibrose Pulmonar/etiologia , Fibrose Pulmonar/patologia , Tromboflebite/etiologia , Tromboflebite/patologiaRESUMO
OBJETIVO: Descrever as lesões pulmonares em uma série de necropsias de pacientes com idade de até 15 anos, falecidos em unidade de terapia intensiva, submetidos ou não à nutrição parenteral total. MÉTODOS: Seis fragmentos de cada pulmão de 114 crianças foram corados por métodos de rotina. Dos prontuários foram obtidas informações referentes aos dados demográficos, clínicos e de terapêutica. Para a análise estatística, foi utilizado o Programa Statistical Package for the Social Sciences. RESULTADOS: Os 114 pacientes foram separados em dois grupos: 50 foram tratados com NPT contendo emulsão de lipídios e os 64 restantes, sem nutrição parenteral total. Os grupos eram semelhantes em relação ao sexo (p = 0,654), à idade (p = 0,682) e ao peso (p = 0,175), e apresentavam diferenças significativas no que tange às seguintes variáveis: tempo de internação (p = 0,000), prematuridade (p = 0,008) e tratamento com hemoderivados (p = 0,009). Todos foram submetidos à ventilação mecânica durante o período de internação. Na análise univariada, as lesões relacionadas à nutrição parenteral total foram: dano alveolar difuso (p = 0,022), fibrose pulmonar (p = 0,019), hiperplasia de pneumócitos (p = 0,004), microtromboembolismo (p = 0,047) e tromboflebite (p = 0,033). A análise multivariada, levando em consideração a prematuridade, o tempo de internação e a idade, mostrou que apenas a fibrose estava relacionada, de modo independente, ao uso da nutrição parenteral total. CONCLUSAO: Embora as lesões pulmonares tenham sido mais freqüentes em pacientes tratados com nutrição parenteral total, não foi possível concluir que essa tenha sido diretamente responsável pela origem das lesões, tendo em vista que co-fatores como prematuridade e tempo de internação influenciaram significativamente no seu aparecimento.
Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lactente , Pré-Escolar , Criança , Adolescente , Unidades de Terapia Intensiva Pediátrica , Pulmão/patologia , Nutrição Parenteral Total , Hiperplasia/etiologia , Hiperplasia/patologia , Tempo de Internação , Modelos Logísticos , Análise Multivariada , Nutrição Parenteral Total/efeitos adversos , Alvéolos Pulmonares/patologia , Embolia Pulmonar/etiologia , Embolia Pulmonar/patologia , Fibrose Pulmonar/etiologia , Fibrose Pulmonar/patologia , Tromboflebite/etiologia , Tromboflebite/patologiaRESUMO
Spinal column deformity is associated with potentially serious alterations of respiratory and cardiac function. Such alterations, in association with the underlying disease that caused the deformity--such as neuromuscular disease--are risk factors that affect the prognosis for scoliosis patients undergoing anesthesia and surgery. It is important for the anesthesiologist to carry out a detailed preoperative assessment to identify patients at risk with the aim of decreasing morbidity and mortality related to surgical correction of deformities. Of paramount importance is awareness of the risk of injury to the spinal cord that will affect function. Other issues are how to manage the patient in anomalous positions, the risk associated with hypothermia secondary to exposure of a large surgical field for a long period, and bleeding, which can sometimes exceed the patient's total volume. In the case of scoliosis surgery, all those situations may converge, obliging us to provide careful intraoperative monitoring, particularly of spinal function; to choose the appropriate anesthetic technique; and to maintain vigilance during the early postoperative period to foresee possible complications. Because scoliosis surgery is multidisciplinary, several teams must work together to assure success.
Assuntos
Anestesia/métodos , Cuidados Pré-Operatórios , Escoliose/cirurgia , Perda Sanguínea Cirúrgica , Transfusão de Sangue Autóloga , Quilotórax/etiologia , Quilotórax/prevenção & controle , Comorbidade , Potenciais Somatossensoriais Evocados , Cardiopatias/etiologia , Testes de Função Cardíaca , Humanos , Íleus/etiologia , Íleus/prevenção & controle , Cuidados Intraoperatórios , Complicações Intraoperatórias/prevenção & controle , Monitorização Intraoperatória , Exame Neurológico , Doenças Neuromusculares/complicações , Equipe de Assistência ao Paciente , Exame Físico , Complicações Pós-Operatórias/prevenção & controle , Troca Gasosa Pulmonar , Transtornos Respiratórios/etiologia , Respiração Artificial , Medição de Risco , Escoliose/complicações , Tromboflebite/etiologia , Tromboflebite/prevenção & controleRESUMO
La deformidad de la columna se asocia con alteraciones, en ocasiones graves, de la función respiratoria y cardiaca. Estas alteraciones, junto con la patología propia de la enfermedad causal de la deformidad por ejemplo en las deformidades secundarias a las enfermedades neuromusculares son factores de riesgo que modifican el pronóstico anestésico-quirúrgico de los pacientes con escoliosis. Desde el punto de vista anestesiológico es importante realizar una cuidadosa evaluación preoperatoria con el fin de identificar a los pacientes de riesgo, para disminuir la morbimortalidad asociada a la correción quirúrgica de su deformidad. Deberemos de tener en cuenta, en primer lugar, el riesgo de lesión de la función espinal o lesión medular. El manejo del paciente en posiciones anómalas, el riesgo asociado de hipotermia, secundaria a la exposición de un gran campo quirúrgico con una cirugía de larga duración, y el sangrado total, que en ocasiones puede superar la volemia del paciente. En la cirugía de la escoliosis es muy probable que todas estas condiciones puedan asociarse en un mismo procedimiento, obligándonos por ello a ser cuidadosos en la monitorización intraoperatoria, sobre todo en la de la función espinal, en la elección de una técnica anestésica adecuada y en un correcto seguimiento de la evolución postoperatoria inmediata para prever todas las posibles complicaciones que nos puedan aparecer. Por su carácter multidisciplinar, se trata de una cirugía en la que es imprescindible la colaboración entre los diferentes equipos participantes para asegurar el éxito del procedimiento
Spinal column deformity is associated with potentially serious alterations of respiratory and cardiac function. Such alterations, in association with the underlying disease that caused the deformitysuch as neuromuscular diseaseare risk factors that affect the prognosis for scoliosis patients undergoing anesthesia and surgery. It is important for the anesthesiologist to carry out a detailed preoperative assessment to identify patients at risk with the aim of decreasing morbidity and mortality related to surgical correction of deformities. Of paramount importance is awareness of the risk of injury to the spinal cord that will affect function. Other issues are how to manage the patient in anomalous positions, the risk associated with hypothermia secondary to exposure of a large surgical field for a long period, and bleeding, which can sometimes exceed the patients total volume. In the case of scoliosis surgery, all those situations may converge, obliging us to provide careful intraoperative monitoring, particularly of spinal function; to choose the appropriate anesthetic technique; and to maintain vigilance during the early postoperative period to foresee possible complications. Because scoliosis surgery is multidisciplinary, several teams must work together to assure success
Assuntos
Humanos , Anestesia/métodos , Cuidados Pré-Operatórios , Escoliose/cirurgia , Perda Sanguínea Cirúrgica , Transfusão de Sangue Autóloga , Quilotórax/etiologia , Quilotórax/prevenção & controle , Comorbidade , Potenciais Somatossensoriais Evocados , Cardiopatias/etiologia , Íleus/etiologia , Íleus/prevenção & controle , Cuidados Intraoperatórios , Complicações Intraoperatórias/prevenção & controle , Monitorização Intraoperatória , Exame Neurológico , Doenças Neuromusculares/complicações , Equipe de Assistência ao Paciente , Exame Físico , Complicações Pós-Operatórias/prevenção & controle , Troca Gasosa Pulmonar , Transtornos Respiratórios/etiologia , Respiração Artificial , Medição de Risco , Escoliose/complicações , Tromboflebite/etiologia , Tromboflebite/prevenção & controle , Testes de Função CardíacaRESUMO
The aim of this study was to evaluate the occurrence of deep venous thrombosis (DVT) and superficial vein thrombosis (SVT) and its prophylaxis with an oral anti-edema and antithrombotic agent (Pycnogenol, Horphag, Research Management SA, Geneva, Switzerland) in long-haul flights, in subjects at moderate to high-risk of DVT and SVT. The study pre-included 244 pre-selected subjects; 211 were included (33 were excluded for several reasons due to logistic problems) and 198 completed the study; 13 subjects were lost for follow-up at the end of the flight, all for non-medical problems (i.e., for difficult connections). All subjects were scanned within 90 minutes before the flight and within 2 hours after disembarking. Subjects were supplemented with 100 mg Pycnogenol per capsule. Treatment subjects received two capsules between 2 and 3 hours before flights with 250 mL of water; two capsules were taken 6 hours later with 250 mL of water and one capsule the next day. The control group received comparable placebo at the same intervals. The flight duration was on average 8 hours and 15 minutes (SD 55 min) (range, 7.45-12.33). In the control group there were five thrombotic events (one DVT and four superficial thromboses) while only nonthrombotic, localized phlebitis was observed in the Pycnogenol group (5.15% vs. no events; p<0.025). The ITT (intention to treat) analysis detects 13 failures in the control group (eight lost to follow up + five thrombotic events) of 105 subjects (12.4%) vs. five failures (4.7%; all lost, no thrombotic events) in the treatment group (p<0.025). No unwanted effects were observed. In conclusion, this study indicates that Pycnogenol treatment was effective in decreasing the number of thrombotic events (DVT and SVT) in moderate-to-high risk subjects, during long-haul flights.
Assuntos
Flavonoides/administração & dosagem , Inibidores da Agregação Plaquetária/administração & dosagem , Tromboflebite/prevenção & controle , Viagem , Trombose Venosa/prevenção & controle , Aviação , Exercício Físico , Veia Femoral/diagnóstico por imagem , Humanos , Incidência , Extratos Vegetais , Veia Poplítea/diagnóstico por imagem , Pré-Medicação , Tromboflebite/tratamento farmacológico , Tromboflebite/etiologia , Tíbia/irrigação sanguínea , Tíbia/diagnóstico por imagem , Resultado do Tratamento , Ultrassonografia , Trombose Venosa/tratamento farmacológico , Trombose Venosa/etiologiaRESUMO
The purpose of this study was to evaluate the efficacy of concurrent chemotherapy and irradiation in inflammatory breast cancer (IBC). Between January 1990 and December 1998, forty-eight non-metastatic patients with clinical or occult IBC were treated with chemotherapy and irradiation. The induction chemotherapy consisted of epirubicin, cyclophosphamide and vindesin, in association with split-course bi-fractionated irradiation to a total dose of 65 Gy with concomitant cisplatin and fluorouracil. Maintenance chemotherapy consisted of high-dose methotrexate and 6 cycles of epirubicin, cyclophosphamide and fluorouracil Hormonal treatment was given routinely but mastectomies were not routinely performed. A high rate of locoregional control was obtained in 47 evaluable patients of whom 93.6 % achieved a complete clinical response. Three patients had locoregional relapses, always with concomitant metastatic dissemination. In 47 patients, 21 developed metastatic dissemination with a median delay of 23 months. Median disease-free survival (DFS) was 45 months. Median overall survival (OS) has not yet been reached after a median follow-up of 44.5 months. The 3-year DFS rate was 53 % and the 3-year OS rate was 71 %. Toxicity was mainly hematological. During the induction therapy, grade 3 or 4 neutropenia occurred in 54 % of patients, grade 3 or 4 thrombocytopenia in 23 % and grade 3 or 4 anemia in 8 %. The administration of induction chemotherapy and concomitant irradiation is feasible in patients with IBC. The hematological toxicity of this treatment approach is significant but nevertheless, the treatment achieves a high degree of locoregional control and improved survivaL
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Carcinoma Ductal de Mama/tratamento farmacológico , Radioterapia Adjuvante , Adulto , Idoso , Antineoplásicos Hormonais/efeitos adversos , Antineoplásicos Hormonais/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Neoplasias da Mama/mortalidade , Neoplasias da Mama/patologia , Neoplasias da Mama/radioterapia , Carcinoma Ductal de Mama/mortalidade , Carcinoma Ductal de Mama/patologia , Carcinoma Ductal de Mama/radioterapia , Carcinoma Lobular/tratamento farmacológico , Carcinoma Lobular/mortalidade , Carcinoma Lobular/patologia , Carcinoma Lobular/radioterapia , Terapia Combinada , Ciclofosfamida/administração & dosagem , Ciclofosfamida/efeitos adversos , Intervalo Livre de Doença , Fracionamento da Dose de Radiação , Epirubicina/administração & dosagem , Epirubicina/efeitos adversos , Feminino , Fluoruracila/administração & dosagem , Fluoruracila/efeitos adversos , Seguimentos , Hormônio Liberador de Gonadotropina/agonistas , Doenças Hematológicas/induzido quimicamente , Humanos , Tábuas de Vida , Menopausa , Metotrexato/administração & dosagem , Metotrexato/efeitos adversos , Pessoa de Meia-Idade , Metástase Neoplásica , Indução de Remissão , Análise de Sobrevida , Tamoxifeno/uso terapêutico , Tromboflebite/etiologia , Resultado do Tratamento , Vindesina/administração & dosagem , Vindesina/efeitos adversosRESUMO
Today hyperhomocysteinemia is a well known and important risk factor for arteriosclerotic vascular and venous thromboembolic disease with a high prevalence in the general population. Elevation of plasma homocysteine levels are caused either by genetic defects in the enzymes involved in homocysteine metabolism or by nutritional deficiencies of vitamin cofactors (folate, vitamin B12, vitamin B6). A number of other factors may influence homocysteine metabolism, such as several disease states and medications. It has been demonstrated, that supplementation of folate, vitamin B12, or vitamin B6 can correct mild and moderate hyperhomocysteinemia.
Assuntos
Doença Celíaca/complicações , Hiper-Homocisteinemia/etiologia , Trombofilia/etiologia , Tromboflebite/etiologia , Adulto , Doença Celíaca/diagnóstico , Diagnóstico Diferencial , Feminino , Humanos , Hiper-Homocisteinemia/diagnóstico , Fatores de Risco , Trombofilia/diagnóstico , Tromboflebite/diagnósticoRESUMO
BACKGROUND/PURPOSE: Vascular injuries in neonates are a rare complication of the varied invasive procedures performed in these small children. Unfortunately there remains a reluctance to repair these injuries early, often because of the relative small size of the affected vessels and the nature of the patient's underlying medical condition. The authors report a consecutive series of patients treated for arterial and venous injuries early in their course using a variety of microsurgical techniques. METHODS: A retrospective chart review was performed of consecutive patients (n = 7) treated over a 2-year period. All had injury as a result of invasive procedures performed in the neonatal period. Both arterial and venous injuries that required some form of intervention were included. RESULTS: Five arterial and two venous injuries were identified. Surgical thrombectomy and microvascular repair was required in two patients. Primary healing occurred despite prolonged (>13 hours) warm ischemia time. Pseudoaneurysms of the brachial artery and radial artery were controlled with surgical ligation, and one patient required bilateral fasciotomies for compartment syndromes related to severe spasm of the common femoral arteries. Phlegmasia cerulea dolens of the lower extremity (n = 2) was treated with leech therapy. All patients healed without tissue loss or functional deficit. CONCLUSIONS: A variety of microvascular interventions have application to the treatment of acute vascular injuries in neonates. Early, aggressive use of these techniques can provide effective therapy for these potentially devastating injuries and allow for complete limb recovery without tissue loss.
Assuntos
Falso Aneurisma/etiologia , Cateterismo Cardíaco/efeitos adversos , Artéria Femoral , Veia Ilíaca , Trombose/etiologia , Animais , Artéria Braquial , Humanos , Recém-Nascido , Sanguessugas , Ligadura , Artéria Radial , Estudos Retrospectivos , Tromboflebite/etiologiaRESUMO
The amino-acid homocysteine plays a crucial role in cell metabolism. It participates in the remethylation pathway enabling maintenance of adequate cellular levels of methionine or is catabolized by transsulphuration. A number of hereditary defects in the enzymes involved in homocysteine metabolism and acquired deficiencies in the vitamin cofactors of these enzymes are associated with the development of hyperhomocysteinaemia. The association between high circulating homocysteine levels and premature vascular thrombosis is well established in individuals with hereditary homocystinuria. There is now good epidemiological evidence that mild hyperhomocysteinaemia is an independent risk factor in the development of arterial disease and venous thrombosis although the causes of the elevated plasma homocysteine are unclear. A good candidate is homozygosity for the common thermolabile variant of methylenetetrahydrofolate reductase but the evidence for a causative association is conflicting. A number of in vitro effects of homocysteine on vascular endothelium, platelets and coagulation have been described which may predispose to vascular disease but the exact in vivo mechanisms remain to be elucidated. Dietary folate supplementation may normalize homocysteine in hyperhomocysteinaemic individuals and modify the risk of vascular disease.
Assuntos
Homocisteína/sangue , Tromboflebite/sangue , Doenças Vasculares/sangue , Artérias , Estudos de Casos e Controles , Ensaios Clínicos Controlados como Assunto , Suscetibilidade a Doenças , Humanos , Fatores de Risco , Tromboflebite/etiologia , Doenças Vasculares/etiologiaRESUMO
An elevated plasma homocysteine level may result from various environmental and genetic factors. Herediatary causes of severe hyperhomo-cysteinaemia are very rare and usually lead to disease in childhood or adolescence. Common pathology consists of early atherosclerotic vascular changes, arterioocclusive complications and venous thrombosis. Mildly elevated genetically determined plasma homocysteine levels are observed in 5% of the general population. In the last two decades research has shown mild hyperhomocysteinaemia to be linked to an increased risk of premature atherosclerosis, pregnancies complicated by neural tube defects and early pregnancy loss, and venous thrombosis. Homozygosity for thermolabile MTHFR deficiency has been identified as one important genetic factor, which expression is modified by dietary folate intake. Although mild hyperhomocysteinaemia can easily be treated by vitamin supplementation the beneficial effects of such treatment remains to be shown.
Assuntos
Homocisteína/sangue , Homocistinúria/fisiopatologia , Erros Inatos do Metabolismo/sangue , Oxirredutases/deficiência , 5,10-Metilenotetra-Hidrofolato Redutase (FADH2) , Arteriosclerose/epidemiologia , Arteriosclerose/etiologia , Feminino , Homocistinúria/sangue , Homocistinúria/tratamento farmacológico , Homocistinúria/genética , Homozigoto , Humanos , Liases/deficiência , Erros Inatos do Metabolismo/etiologia , Erros Inatos do Metabolismo/genética , Erros Inatos do Metabolismo/fisiopatologia , Metilenotetra-Hidrofolato Redutase (NADPH2) , Defeitos do Tubo Neural/epidemiologia , Defeitos do Tubo Neural/etiologia , Gravidez , Complicações na Gravidez/epidemiologia , Complicações na Gravidez/etiologia , Tromboflebite/epidemiologia , Tromboflebite/etiologiaRESUMO
BACKGROUND AND OBJECTIVE: In spite of the large number of reports showing that hyperhomocysteinemia (HHcy) is an independent risk factor for atherosclerosis and arterial occlusive disease, this metabolite of the methionine pathway is measured in relatively few laboratories and its importance is not fully appreciated. Recent data strongly suggest that mild HHcy is also involved in the pathogenesis of venous thromboembolic disease. The aim of this paper is to analyze the most recent advances in this field. EVIDENCE AND INFORMATION SOURCES: The material examined in the present review includes articles and abstracts published in journals covered by the Science Citation Index and Medline. In addition the authors of the present article have been working in the field of mild HHcy as cause of venous thromboembolic disease. STATE OF ART AND PERSPECTIVES: The studies examined provide very strong evidence supporting the role of moderate HHcy in the development of premature and/or recurrent venous thromboembolic disease. High plasma homocysteine levels are also a risk factor for deep vein thrombosis in the general population. Folic acid fortification of food has been proposed as a major tool for reducing coronary artery disease mortality in the United States. Vitamin supplementation may also reduce recurrence of venous thromboembolic disease in patients with HHcy. At the present time, however, the clinical efficacy of this approach has not been tested. In addition, the bulk of evidence indicates that fasting total homocysteine determinations can identify up to 50% of the total population of hyperhomocysteinemic subjects. Patients with isolated methionine intolerance may benefit from vitamin B6 supplementation. Homocysteine-lowering vascular disease prevention trials are urgently needed. Such controlled studies, however, should not focus exclusively on fasting homocysteine determinations and folic acid monotherapy.
Assuntos
Homocisteína/sangue , Tromboflebite/etiologia , Humanos , Fatores de RiscoRESUMO
Deep venous thrombosis and subsequent pulmonary embolism due to venous pooling/stasis commonly occur in patients during hip and/or knee arthroplasty (i.e., replacement). This problem may be alleviated by using techniques to promote lower limb blood flow. Electrical stimulation-induced contractions have been shown to activate the skeletal muscle pump, promote limb blood flow, and may be effective for reducing venous pooling/stasis and edema. Therefore, electrical stimulation may reduce the incidence of deep venous thrombosis (DVT) and pulmonary embolism (PE) during and following surgery. The overall goal of this project was to evaluate the clinical efficacy of sequential electrical stimulation-induced leg muscle contractions on the venous blood flow during surgery. The degree of venous pooling/stasis was monitored via electrical impedance changes in the thorax. The changes in the patient's central hemodynamics were then calculated. Thirty patients were recruited and randomly assigned to either a control group (n = 15, mean age = 66.4 +/- 7.3) or experimental group (n = 15, age = 60.7 +/- 9.7). Both groups received the standard medical treatment for prevention of DVT (i.e., coumadin, heparin, etc.) and compression stockings (TED, Kendall). The control group used the sequential compression device (SCD + TED) and the experimental group used electrical stimulation (ES + TED). Electrical stimulation was applied via surface electrodes to the lower-limb muscles (tibialis anterior and gastrocnemius) and upper limb muscles (quadriceps femoris and hamstrings). These muscles contracted sequentially, using an eight-channel electrical stimulator. Four seconds of calf (contraction/compression) were followed by 7-s of calf and thigh (contraction/compression) interspersed by 60-s rest period during both electrical stimulation or sequential compression device. This cycle continued throughout the surgery (60-75 min) for both groups. At 15 min intervals, venous return was monitored by impedance cardiograph. Physiologic responses including ventricular stroke volume (SV), cardiac output (CO), heart rate (HR), total peripheral resistance (TPR), as well as mean arterial pressure (MAP) were monitored. These responses were statistically analyzed and compared throughout the surgery within each group and between the two groups. The results show stroke volume and cardiac output to be higher throughout surgery in the electrical stimulation group as compared with the sequential compression device group. The heart rate was consistently lower during electrical stimulation for both groups. Total peripheral resistance did not change in the electrical stimulation group; but increased in the sequential compression device group. The data suggest that continuous electrical stimulation-induced contractions could improve lower leg circulation by eliciting the physiologic muscle pump. This will lead to improved venous circulation and reduction of blood stasis during total hip and/or knee surgery. This technique may offer greater protection against DVT and PE during surgery than the commonly used sequential compression device.
Assuntos
Terapia por Estimulação Elétrica/métodos , Prótese de Quadril/efeitos adversos , Prótese do Joelho/efeitos adversos , Contração Muscular , Tromboflebite/prevenção & controle , Bandagens , Feminino , Hemodinâmica , Humanos , Cuidados Intraoperatórios , Masculino , Pessoa de Meia-Idade , Monitorização Intraoperatória , Tromboflebite/etiologiaRESUMO
Patients with the rare homozygous hereditary defects of homocysteine metabolism that cause severe hyperhomocysteinemia and homocystinuria are at high risk of arterial and venous thrombosis. This prompted studies of the relationship between moderate hyperhomocysteinemia and thrombotic risk in the general population. In the last 2 decades, retrospective case-control studies and prospective cohort studies have demonstrated moderate hyperhomocysteinemia to be a frequent and independent risk factor for premature vascular disease in the coronary, cerebral, and peripheral arteries. More recently, the association of moderate hyperhomocysteinemia with venous thrombosis was shown in patients with early-onset or recurrent disease and in the general population. Genetic and environmental factors act in concert to cause moderate hyperhomocysteinemia. Since inadequate intake of folic acid, vitamin B12, or vitamin B6 are most frequently associated with hyperhomocysteinemia, dietary supplementation of these vitamins could have a tremendous impact on the epidemiology and natural history of arterial and venous thrombotic diseases.
Assuntos
Erros Inatos do Metabolismo dos Aminoácidos/complicações , Homocisteína/sangue , Trombose/etiologia , Erros Inatos do Metabolismo dos Aminoácidos/tratamento farmacológico , Erros Inatos do Metabolismo dos Aminoácidos/etiologia , Arteriosclerose/etiologia , Humanos , Fatores de Risco , Tromboflebite/sangue , Tromboflebite/etiologia , Tromboflebite/genética , Trombose/sangue , Trombose/genética , Vitaminas/uso terapêuticoRESUMO
BACKGROUND: The acquired immunodeficiency syndrome (AIDS) is frequently complicated by malnutrition that may require parenteral nutritional support. In a non-AIDS population with long-term indwelling central venous catheters, low-dose warfarin therapy has been shown to prevent venous thrombosis. The purpose of this study was to determine the incidence of symptomatic central venous thrombosis in AIDS patients receiving home parenteral nutrition. The incidence of thrombosis on low-dose warfarin was compared with no prophylactic therapy. METHODS: A retrospective review of 47 malnourished AIDS patients started on home parental nutrition was performed. None of the patients had a prior history of venous thrombosis. During this period, 9 of 47 patients were treated with low-dose warfarin therapy. The incidence of clinical and radiologic venous thrombosis was compared in these two groups. RESULTS: Forty-seven patients were treated with parenteral nutrition for 296 patients-months. The rate of central venous thrombosis in patients receiving warfarin (0.016 thromboses per patient-month) was no different from those patients on no prophylactic therapy (0.009 thromboses per patient-month). The most common abnormality in coagulation observed in the entire group during follow-up was thrombocytopenia occurring in 66% of patients. Sixty percent of patients received medications that could interfere with platelet function. CONCLUSIONS: We conclude that routine thrombosis prophylaxis with low-dose warfarin may not be justified in malnourished AIDS patients receiving home parenteral nutrition. Prospective clinical trials are needed to determine the risks and benefits of prophylactic warfarin therapy in this group of patients.